Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Toward a Controlled Human Infection Model of Pertussis.

Literature DB >> 31552410

Toward a Controlled Human Infection Model of Pertussis.

Tod J Merkel¹.

Abstract

Entities: Species

Keywords: zzm321990 Bordetella pertussiszzm321990 ; human challenge; immunity; pathogenesis; vaccine

Year: 2020 PMID： 31552410 PMCID： PMC7353834 DOI： 10.1093/cid/ciz842

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

× No keyword cloud information.

37 in total

1. Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters.

Authors: Ricardo da Silva Antunes; Mariana Babor; Chelsea Carpenter; Natalie Khalil; Mario Cortese; Alexander J Mentzer; Grégory Seumois; Christopher D Petro; Lisa A Purcell; Pandurangan Vijayanand; Shane Crotty; Bali Pulendran; Bjoern Peters; Alessandro Sette
Journal: J Clin Invest Date: 2018-08-06 Impact factor: 14.808

2. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.

Authors: Maxwell A Witt; Paul H Katz; David J Witt
Journal: Clin Infect Dis Date: 2012-03-15 Impact factor: 9.079

3. Waning immunity to pertussis following 5 doses of DTaP.

Authors: Sara Y Tartof; Melissa Lewis; Cynthia Kenyon; Karen White; Andrew Osborn; Juventila Liko; Elizabeth Zell; Stacey Martin; Nancy E Messonnier; Thomas A Clark; Tami H Skoff
Journal: Pediatrics Date: 2013-03-11 Impact factor: 7.124

4. Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis.

Authors: Tami H Skoff; Stacey W Martin
Journal: JAMA Pediatr Date: 2016-05-01 Impact factor: 16.193

5. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal: MMWR Recomm Rep Date: 2018-04-27

6. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal.

Authors: F Simondon; M P Preziosi; A Yam; C T Kane; L Chabirand; I Iteman; G Sanden; S Mboup; A Hoffenbach; K Knudsen; N Guiso; S Wassilak; M Cadoz
Journal: Vaccine Date: 1997-10 Impact factor: 3.641

7. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.

Authors: L Gustafsson; H O Hallander; P Olin; E Reizenstein; J Storsaeter
Journal: N Engl J Med Date: 1996-02-08 Impact factor: 91.245

8. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.

Authors: C L Cody; L J Baraff; J D Cherry; S M Marcy; C R Manclark
Journal: Pediatrics Date: 1981-11 Impact factor: 7.124

9. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates.

Authors: J M Warfel; T J Merkel
Journal: Mucosal Immunol Date: 2012-11-28 Impact factor: 7.313

Review 3. The History of Pertussis Toxin.

Authors: Camille Locht; Rudy Antoine
Journal: Toxins (Basel) Date: 2021-09-05 Impact factor: 4.546

4. Mucosal Immunization Against Pertussis: Lessons From the Past and Perspectives.

Authors: Violaine Dubois; Camille Locht
Journal: Front Immunol Date: 2021-06-15 Impact factor: 7.561

4 in total